Site name unknown, Munchen

Phase	Trial	Trial Status [asc]	Site Status	Drug	NCT#
2	Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib. (OPEN)	Active, not recruiting	Closed	Nilotinib	NCT00756509
3	Efficacy and Safety of AMN107 Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib (ENEST)	Completed	Closed	Nilotinib	NCT00471328
2	Treatment of Patients With Everolimus and Imatinib Mesylate Who Have Progressive Gastro Intestinal Stromal Tumors (GIST) and Are Resistant to Imatinib Mesylate	Completed	Closed	Imatinib + RAD001	NCT00510354
2	Treatment of Patients With RAD001 Who Have Progressive Sarcoma	Completed	Closed	Everolimus	NCT00767819